Name | Number of supported studies | Average coverage | |
---|---|---|---|
myofibroblast cell | 8 studies | 26% ± 6% | |
smooth muscle cell | 8 studies | 26% ± 5% | |
connective tissue cell | 7 studies | 22% ± 7% | |
endothelial cell | 7 studies | 27% ± 12% | |
fibroblast | 7 studies | 24% ± 6% | |
goblet cell | 7 studies | 30% ± 12% | |
pericyte | 7 studies | 24% ± 7% | |
epithelial cell | 7 studies | 34% ± 20% | |
ciliated cell | 6 studies | 31% ± 9% | |
platelet | 5 studies | 22% ± 4% | |
hematopoietic precursor cell | 4 studies | 28% ± 12% | |
classical monocyte | 4 studies | 23% ± 6% | |
abnormal cell | 4 studies | 23% ± 5% | |
macrophage | 4 studies | 22% ± 6% | |
dendritic cell | 4 studies | 32% ± 10% | |
conventional dendritic cell | 3 studies | 34% ± 13% | |
non-classical monocyte | 3 studies | 34% ± 7% | |
extravillous trophoblast | 3 studies | 32% ± 9% | |
basal cell | 3 studies | 36% ± 15% | |
melanocyte | 3 studies | 43% ± 26% | |
hematopoietic stem cell | 3 studies | 24% ± 6% | |
plasmacytoid dendritic cell | 3 studies | 23% ± 4% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3287.94 | 180 / 180 | 100% | 64.03 | 430 / 430 |
thymus | 100% | 4206.90 | 653 / 653 | 100% | 66.64 | 605 / 605 |
uterus | 100% | 4511.92 | 170 / 170 | 100% | 78.46 | 459 / 459 |
prostate | 100% | 7320.96 | 245 / 245 | 100% | 192.22 | 501 / 502 |
skin | 100% | 4663.16 | 1809 / 1809 | 100% | 165.10 | 471 / 472 |
esophagus | 100% | 4941.81 | 1445 / 1445 | 99% | 50.56 | 182 / 183 |
breast | 100% | 4921.12 | 459 / 459 | 99% | 94.29 | 1109 / 1118 |
kidney | 100% | 4475.99 | 89 / 89 | 99% | 47.88 | 893 / 901 |
intestine | 100% | 4747.75 | 966 / 966 | 99% | 54.19 | 522 / 527 |
liver | 100% | 2483.09 | 226 / 226 | 99% | 36.79 | 401 / 406 |
bladder | 100% | 3986.71 | 21 / 21 | 98% | 66.80 | 496 / 504 |
stomach | 100% | 3570.26 | 359 / 359 | 98% | 46.22 | 281 / 286 |
lung | 100% | 3725.22 | 576 / 578 | 98% | 50.54 | 1137 / 1155 |
pancreas | 100% | 1891.18 | 328 / 328 | 97% | 53.56 | 173 / 178 |
brain | 82% | 1080.98 | 2154 / 2642 | 98% | 48.64 | 691 / 705 |
adrenal gland | 100% | 3322.93 | 258 / 258 | 72% | 28.57 | 165 / 230 |
adipose | 100% | 3983.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4823.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 119.92 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.68 | 29 / 29 |
spleen | 100% | 3962.03 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 66.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 98.73 | 1 / 1 |
heart | 98% | 1731.94 | 842 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2111.80 | 903 / 929 | 0% | 0 | 0 / 0 |
muscle | 91% | 1103.24 | 728 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0010468 | Biological process | regulation of gene expression |
GO_0016925 | Biological process | protein sumoylation |
GO_0033234 | Biological process | negative regulation of protein sumoylation |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0005694 | Cellular component | chromosome |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HMG20B |
Protein name | HMG20B protein High mobility group 20B SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related (SMARCE1-related protein) (BRCA2-associated factor 35) (HMG box-containing protein 20B) (HMG domain-containing protein 2) (HMG domain-containing protein HMGX2) (Sox-like transcriptional factor) (Structural DNA-binding protein BRAF35) |
Synonyms | HMGX2 HMGXB2 SMARCE1R BRAF35 |
Description | FUNCTION: Required for correct progression through G2 phase of the cell cycle and entry into mitosis. Required for RCOR1/CoREST mediated repression of neuronal specific gene promoters. |
Accessions | K7EJR8 ENST00000453933.5 A4IF61 F8WES5 ENST00000435022.5 C9J8X5 ENST00000333651.11 [Q9P0W2-1] Q9P0W2 C9JQA7 ENST00000416526.5 ENST00000262949.7 C9K049 B5MDG7 ENST00000585900.1 ENST00000417382.5 |